Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Selenium sulfide by Azura Ophthalmics for Keratoconjunctivitis Sicca (Dry Eye): Likelihood of Approval
Selenium sulfide is under clinical development by Azura Ophthalmics and currently in Phase III for Keratoconjunctivitis Sicca (Dry Eye). According...
Selenium sulfide by Azura Ophthalmics for Unspecified Ophthalmological Disorders: Likelihood of Approval
Selenium sulfide is under clinical development by Azura Ophthalmics and currently in Phase II for Unspecified Ophthalmological Disorders. According to...
Selenium sulfide by Azura Ophthalmics for Meibomian Blepharitis: Likelihood of Approval
Selenium sulfide is under clinical development by Azura Ophthalmics and currently in Phase III for Meibomian Blepharitis. According to GlobalData,...